Collaboration, License, and Other Agreements - North America - Royalty Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Revenues:
Revenue	$ 108,637	$ 103,747	$ 303,397	$ 296,623
Collaborative arrangements revenue
Revenues:
Revenue	108,637	103,747	303,397	295,798
Collaborative arrangements revenue | North America | AbbVie
Revenues:
Revenue	106,085	101,061	296,047	288,598
Collaborative arrangement, collaboration and license agreements | North America | AbbVie
Revenues:
Revenue	106,085	101,061	296,047	288,598
Royalty | AbbVie
Revenues:
Revenue	700	700	1,800	1,900
Royalty | North America | AbbVie
Revenues:
Revenue	861	668	2,052	1,949
Royalty | Canada and Mexico | AbbVie
Revenues:
Revenue	$ 900	$ 700	$ 2,100	$ 1,900